EUVIMEDEUVIMED entdecken
Open Access

An open‐label 16‐week study of liraglutide in adolescents with obesity post‐sleeve gastrectomy

Anna Zenno, Ejike E Nwosu, Syeda Z Fatima, Evan P Nadler, Nazrat M Mirza, Sheila M Brady, Sara A Turner, Shanna B Yang, Julia Lazareva, Jennifer A Te-Vasquez, Kong Y Chen, Stephanie T Chung iD und 1 weitere

Pediatric Obesity · 2024

DOI: 10.1111/ijpo.13154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Obesity, 2024. Verfasst von Anna Zenno und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section on Growth and Obesity, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICH…. Hauptthemen laut MEDLINE: Liraglutide, Gastrectomy, Pediatric Obesity, Weight Loss. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Up to 50% of adolescents who undergo metabolic and bariatric surgery (MBS) have obesity 3 years post‐MBS, placing them at continued risk for the consequences of obesity.

Objectives

We conducted an open‐label, 16‐week pilot study of liraglutide in adolescents with obesity after sleeve gastrectomy (SG) to investigate liraglutide effects on weight and body mass index (BMI) post‐SG.

Methods

Adolescents aged 12–20.99 years with obesity and a history of SG ≥1 year prior were enrolled. Liraglutide was initiated at 0.6 mg/day, escalated weekly to a maximum of 3 mg/day, with treatment duration 16 weeks. Fasting laboratory assessments and an oral glucose tolerance test were performed at baseline and end‐treatment.

Results

A total of 43 participants were screened, 34 initiated liraglutide (baseline BMI 41.2 ± 7.7 kg/m 2 ), and 31 (91%) attended the end‐treatment visit. BMI decreased by 4.3% ( p < 0.001) with liraglutide. Adolescents who had poor initial response to SG (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideGastrectomyPediatric ObesityWeight LossBody Mass IndexHumansAdolescentFemaleMalePilot ProjectsChildBlood GlucoseYoung AdultHypoglycemic AgentsTreatment OutcomeBariatric SurgeryObesity, MorbidGlycated Hemoglobin

Stichwörter der Autor:innen

GLP1adolescencebariatric surgeryobesitypharmacotherapyweight loss

Substanzen

LiraglutideBlood GlucoseHypoglycemic AgentsGlycated Hemoglobin

Autor:innen und Institutionen

  • Section on Growth and Obesity, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Department of Pediatrics, University of Washington, Seattle, Washington, USA.
  • Children's National Hospital, Washington, DC, USA.
  • Nutrition Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.

ORCID-Profile: Stephanie T Chung, Jack A Yanovski

Förderung

  • Intramural NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases, NIH
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health
  • Office of Research on Women's Health (ORWH), NIH through the Bench-to-Bedside and Back Program
  • NICHD Division of Intramural Research Early Career Award
  • Office of Research on Women's Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Zenno, A., Nwosu, E. E., Fatima, S. Z., Nadler, E. P., Mirza, N. M., Brady, S. M., Turner, S. A., Yang, S. B., Lazareva, J., Te-Vasquez, J. A., Chen, K. Y., Chung, S. T., & Yanovski, J. A. (2024). An open‐label 16‐week study of liraglutide in adolescents with obesity post‐sleeve gastrectomy. Pediatric Obesity. https://doi.org/10.1111/ijpo.13154

Vancouver

Zenno A, Nwosu EE, Fatima SZ, Nadler EP, Mirza NM, Brady SM, et al. An open‐label 16‐week study of liraglutide in adolescents with obesity post‐sleeve gastrectomy. Pediatric Obesity. 2024. doi:10.1111/ijpo.13154

BibTeX
@article{Zenno2024,
  author = {Zenno, Anna and Nwosu, Ejike E and Fatima, Syeda Z and Nadler, Evan P and Mirza, Nazrat M and Brady, Sheila M and Turner, Sara A and Yang, Shanna B and Lazareva, Julia and Te-Vasquez, Jennifer A and Chen, Kong Y and Chung, Stephanie T and Yanovski, Jack A},
  title = {An open‐label 16‐week study of liraglutide in adolescents with obesity post‐sleeve gastrectomy},
  journal = {Pediatric Obesity},
  year = {2024},
  doi = {10.1111/ijpo.13154}
}
Kostenlos starten →